Sunny Pharmtech Inc. (TPEX:6676)
Taiwan · Delayed Price · Currency is TWD 15.90
-0.05 (-0.31%)
At close: Feb 11, 2026
Sunny Pharmtech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -269.51 | -156 | -63.32 | -170.24 | -174.79 | -101.76 |
Depreciation & Amortization | 121.23 | 119.67 | 118.01 | 108.36 | 103.12 | 104.62 |
Other Amortization | 3.64 | 3.35 | 3.21 | 3.33 | 1.74 | 1 |
Loss (Gain) From Sale of Assets | - | -0.08 | 0.08 | 0.09 | - | - |
Asset Writedown & Restructuring Costs | - | - | 1.24 | - | - | 6.18 |
Stock-Based Compensation | 1.26 | 1.37 | 12.63 | 13.07 | 4.17 | - |
Other Operating Activities | 1.75 | 0.89 | -0.5 | -3.66 | 0.59 | 0.03 |
Change in Accounts Receivable | 30.73 | 7.01 | -27.58 | 34.86 | -24.45 | 9.36 |
Change in Inventory | -47.87 | -26.45 | -25.1 | 25.66 | 42.78 | -28.95 |
Change in Accounts Payable | 16.52 | -9.25 | 13.79 | -10.81 | 6.52 | -16.86 |
Change in Unearned Revenue | 26.05 | 23.36 | 11.05 | 12.9 | 3.68 | 7.13 |
Change in Other Net Operating Assets | 3.61 | -0.96 | -5.41 | 13.31 | 2.29 | -6.8 |
Operating Cash Flow | -112.58 | -37.1 | 38.1 | 26.88 | -34.35 | -26.04 |
Operating Cash Flow Growth | - | - | 41.75% | - | - | - |
Capital Expenditures | -33.23 | -45.71 | -143.99 | -179.18 | -158.95 | -65 |
Sale of Property, Plant & Equipment | - | 0.08 | - | - | - | - |
Sale (Purchase) of Intangibles | -6.73 | -3.77 | -1.21 | -16.11 | -1.57 | -3.83 |
Investment in Securities | -10.51 | -36.08 | 59.69 | -31.14 | -53.58 | 39.59 |
Other Investing Activities | 0.02 | 0.27 | -0.35 | 4.81 | 0.31 | 0.66 |
Investing Cash Flow | -50.44 | -85.22 | -85.85 | -221.63 | -213.79 | -28.59 |
Short-Term Debt Issued | - | 20 | - | 140 | 3.28 | 12.62 |
Long-Term Debt Issued | - | - | 55 | 339 | 290 | 20 |
Total Debt Issued | 64 | 20 | 55 | 479 | 293.28 | 32.62 |
Short-Term Debt Repaid | - | - | -190 | - | - | - |
Long-Term Debt Repaid | - | -31.61 | -50.64 | -290.18 | -310.99 | -31.01 |
Total Debt Repaid | -21.92 | -31.61 | -240.64 | -290.18 | -310.99 | -31.01 |
Net Debt Issued (Repaid) | 42.08 | -11.61 | -185.64 | 188.82 | -17.71 | 1.61 |
Issuance of Common Stock | 0.82 | 1.4 | 281.32 | - | 252.7 | - |
Other Financing Activities | - | - | - | -0.44 | 0.44 | - |
Financing Cash Flow | 42.9 | -10.21 | 95.67 | 188.38 | 235.43 | 1.61 |
Net Cash Flow | -120.13 | -132.53 | 47.92 | -6.37 | -12.71 | -53.02 |
Free Cash Flow | -145.81 | -82.81 | -105.88 | -152.3 | -193.31 | -91.04 |
Free Cash Flow Margin | -50.25% | -19.81% | -24.69% | -42.35% | -80.21% | -21.68% |
Free Cash Flow Per Share | -0.98 | -0.56 | -0.74 | -1.10 | -1.45 | -0.70 |
Cash Interest Paid | 9.74 | 9.07 | 11.24 | 8.26 | 5.62 | 6.8 |
Cash Income Tax Paid | - | 0.3 | 0.5 | -0.01 | -0.02 | 0.03 |
Levered Free Cash Flow | -61.52 | -46.2 | -91.48 | -118.38 | -157.65 | -51.13 |
Unlevered Free Cash Flow | -55.43 | -40.54 | -84.45 | -115.52 | -154.14 | -46.89 |
Change in Working Capital | 29.04 | -6.3 | -33.25 | 75.92 | 30.82 | -36.12 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.